[CH:1]1([NH2:5])[CH2:4][CH2:3][CH2:2]1.C([O-])([O-])=O.[K+].[K+].[C:12]([O:16][C:17](=[O:27])[NH:18][C:19]1[CH:24]=[N:23][C:22]([CH2:25]Br)=[CH:21][N:20]=1)([CH3:15])([CH3:14])[CH3:13]>C1COCC1>[C:12]([O:16][C:17](=[O:27])[NH:18][C:19]1[CH:24]=[N:23][C:22]([CH2:25][NH:5][CH:1]2[CH2:4][CH2:3][CH2:2]2)=[CH:21][N:20]=1)([CH3:15])([CH3:14])[CH3:13]In a dried 100 mL round bottom flask was added cyclobutylamine (740 mg, 889 μL, 10.4 mmol, Eq: 3), K2CO3 (480 mg, 3.47 mmol, Eq: 1.00) and THF at rt. under argon. To the mixture was added a solution of (5-Bromomethyl-pyrazin-2-yl)-carbamic acid tert-butyl ester (1 g, 3.47 mmol, Eq: 1.00) in THF dropwise. The resulting reaction mixture was stirred vigorously at room temperature under argon overnight. The reaction was concentrated, diluted with water/DCM and extracted with DCM (2×30 mL). Combined organic extracts were concentrated to give a solid. The crude product was purified by LC chromatography (50 g spherical silica column) eluting with 5 to 10% MeOH in 1/1 EtOAc/Hex to afford 348 mg (36%) of the title compound as a white solid.